Ta. Santora et al., WORKING THROUGH THE PUBLIC DISCLOSURE PROCESS MANDATED BY USE OF 21-CFR-50.24 [EXCEPTION TO INFORMED CONSENT] - GUIDELINES FOR SUCCESS, The journal of trauma, injury, infection, and critical care, 45(5), 1998, pp. 907-913
New Food and Drug Administration guidelines allow research to be done
under an ''exception to informed consent.'' These guidelines mandate a
dvance public disclosure (PD) but provide no specifics for how to acco
mplish this task. This report outlines the history of informed consent
in emergency care situations, highlights the Food and Drug Administra
tion regulations for an exception to informed consent, and describes a
stepwise approach with specific details of a PD program for a study u
sing a blood substitute. This descriptive report can serve as a guidel
ine for subsequent emergency care investigators in the development of
a strategic plan for PD.